相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer
John M. Seligson et al.
ANNALS OF PHARMACOTHERAPY (2021)
Targeting Trop-2 in solid tumors: future prospects
Saif Zaman et al.
ONCOTARGETS AND THERAPY (2019)
Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens
Asmaa Gaber Abdou et al.
CLINICAL PATHOLOGY (2019)
Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update
Shirin Eyvazil et al.
CURRENT CANCER DRUG TARGETS (2018)
Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer
Peng Zhao et al.
MOLECULAR MEDICINE REPORTS (2015)
EpCAM: Structure and function in health and disease
Ulrike Schnell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Overexpression of TROP2 Predicts Poor Prognosis of Patients with Cervical Cancer and Promotes the Proliferation and Invasion of Cervical Cancer Cells by Regulating ERK Signaling Pathway
Ting Liu et al.
PLOS ONE (2013)
Humanized Anti-Trop-2 IgG-SN-38 Conjugate for Effective Treatment of Diverse Epithelial Cancers: Preclinical Studies in Human Cancer Xenograft Models and Monkeys
Thomas M. Cardillo et al.
CLINICAL CANCER RESEARCH (2011)
Trop2: A possible therapeutic target for late stage epithelial carcinomas
Rafael Cubas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule
Monika Trzpis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)